SCHEMBL17211556

SCHEMBL17211556

CC1C(O)[C@H](OC2OC(CO)[C@H](O)[C@H](O[C@]3(C(=O)O)C[C@@H](O)[C@@H](N)C(C(O)C(O)CO)O3)C2O)[C@H](CO)O[C@H]1O[C@@H]1C(O)[C@H](O)C(CO)O[C@@H]1OCC(O[C@H](CO)O[C@@H]1C(CO)O[C@@H](O[C@@H]2C(CO)O[C@@H](C)[C@@H](C)C2O)[C@@H](C)C1O)[C@@H](O)[C@@H](C)O[C@H]1O[C@H](CO)[C@@H](O)C(O)C1O[C@@H]1OC(CO)[C@@H](O)C(O)[C@@H]1C

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ MAG P20916 9/20 0.46
▸ SIGLEC7 Q9Y286 6/20 0.44
▸ SELP P16109 2/20 0.39
▸ SELL P14151 1/20 0.39
▸ SELE P16581 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15849853 0.98 MAG (0.46) MAGSIGLEC7SELPSELLSELE
SCHEMBL17199601 0.94 SIGLEC7 (0.43) MAGSIGLEC7SELPSELLSELE
SCHEMBL16190390 0.92 SIGLEC7 (0.44) MAGSIGLEC7SELPSELLSELE
SCHEMBL16301515 0.92 SIGLEC7 (0.44) MAGSIGLEC7SELPSELLSELE
SCHEMBL15176939 0.92 SIGLEC7 (0.44) MAGSIGLEC7SELPSELLSELE
SCHEMBL17199499 0.91 MAG (0.39) MAGSIGLEC7SELPSELLSELE
SCHEMBL15849877 0.91 SIGLEC7 (0.45) MAGSIGLEC7SELPSELLSELE
SCHEMBL17199639 0.86 SIGLEC7 (0.46) MAGSIGLEC7SELPSELLSELE
SCHEMBL18934180 0.86 MAG (0.51) MAGSIGLEC7SELPSELLSELE
SCHEMBL18333537 0.86 MAG (0.51) MAGSIGLEC7SELPSELLSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150306235-A1 SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME GLYTECH INC (JP) 2015-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150306235-A1 SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME SI, ENGASE, DNPEP MAG 1177/4885SIGLEC7 29/4885SELP 331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback